An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy
- PMID: 38424427
- DOI: 10.2174/0115672018286563240223072702
An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy
Abstract
Background: The clinical efficiency of photodynamic therapy (PDT) in combination with chemotherapy has proven to be a promising strategy for tumor treatment, yet is restricted by the high glutathione (GSH) concentration at the tumor site and nonspecific drug targeting.
Objective: The goal of the current research was to create a biocompatible GSH-depleting and tumor- targeting nanoparticle (denoted as DOX/CA@PCN-224@HA) for the combined photodynamic and chemo photo-chemo) therapy.
Methods: The nanoparticles were characterized by transmission electron microscopy (TEM). A UV-vis spectrophotometer was used to measure the drug loading efficiency (DE) and encapsulation efficiency (EE). The GSH-depleting ability was measured using Ellman's test. Confocal laser scan microscopy (CLSM) was used to assess the cellular uptake. MTT was adopted to evaluate the cytotoxicity of DOX/CA@PCN-224@HA against 4T1 cells.
Results: The altered PCN-224 showed excellent monodispersing with a dimension of approximately 193 nm ± 2 nm in length and 79 nm ± 3 nm in width. The larger and spindle grid-like structure of PCN-224 obtains better dual-drug loading ability (DOX: 20.58% ± 2.60%, CA: 21.81% ± 1.98%) compared with other spherical PCN-224 nanoparticles. The ultimate cumulative drug release rates with hyaluronidase (HAase) were 74% ± 1% (DOX) and 45% ± 2% (CA) after 72 h. DOX/CA@PCN-224@HA showed GSH-consuming capability, which could improve the PDT effect. The drug-loaded nanoparticles could accurately target 4T1 cells through biological evaluations. Moreover, the released DOX and CA display cooperative effects on 4T1 cells in vitro. DOX/CA@PCN-224@HA nanoparticles showed inhibition against 4T1 cells with an IC50 value of 2.71 μg mL-1.
Conclusion: This nanosystem displays great potential for tumor-targeted enhanced (photo-chemo) therapy.
Keywords: FBS.; PDT; Photodynamic therapy; combined therapeutic; metal-organic framework; tumor targeting.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Blackberry-Like Doxorubicin Loaded Hyaluronic Acid/Zinc Phthalocyanine Loaded Mesoporous Silica Nanocomposites for Long-Term Tumor Photodynamic and Chemotherapy Synergistic Therapy.Int J Nanomedicine. 2025 Jul 17;20:9111-9134. doi: 10.2147/IJN.S530041. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40692537 Free PMC article.
-
Hypoxia-Responsive Nano-Photosensitizer Anchored by PEGylated BODIPY: A Single-Laser-Driven Platform for Photo-Enhanced Synergistic Chemo/Photodynamic/Photothermal Cancer Therapy.Mol Pharm. 2025 Sep 1;22(9):5603-5615. doi: 10.1021/acs.molpharmaceut.5c00646. Epub 2025 Aug 13. Mol Pharm. 2025. PMID: 40799084
-
Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.Acta Biomater. 2022 Jan 15;138:463-477. doi: 10.1016/j.actbio.2021.10.032. Epub 2021 Oct 27. Acta Biomater. 2022. PMID: 34718179
-
The safety and efficiency of photodynamic therapy for the treatment of osteosarcoma: A systematic review of in vitro experiment and animal model reports.Photodiagnosis Photodyn Ther. 2022 Dec;40:103093. doi: 10.1016/j.pdpdt.2022.103093. Epub 2022 Aug 27. Photodiagnosis Photodyn Ther. 2022. PMID: 36031143
-
A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.Health Technol Assess. 2010 Jul;14(37):1-288. doi: 10.3310/hta14370. Health Technol Assess. 2010. PMID: 20663420
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources